Latest Current Report
Filed: 2026-01-27
Key Insights
- Waters Corporation is acquiring Becton, Dickinson and Company's Biosciences and Diagnostic Solutions business through a Reverse Morris Trust transaction.
- The transaction was approved by Waters' shareholders, who voted in favor of the share issuance required to complete the merger.
- The transaction is expected to close on February 9, 2026, subject to the satisfaction of remaining customary closing conditions.